Chandra Bhagat Pharma Profit & Loss Annual

BSE: 542934 | NSE: - | ISIN: INE07QQ01016 | Sector: Biotechnology & Drugs

66.53 -5.47 (-7.60%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	221.37	119.67	94.08	70.70
Total Revenue	221.37	119.67	94.08	70.70
Costof Revenue Total	208.04	106.58	81.36	59.74
Gross Profit	13.34	13.09	12.72	10.95
Selling/ General/ Admin Expenses Total	2.66	1.56	1.70	2.04
Depreciation/ Amortization	0.64	0.11	0.04	0.03
Other Operating Expenses Total	17.72	8.21	8.34	5.60
Total Operating Expense	229.06	116.62	91.52	67.41
Operating Income	-7.68	3.06	2.55	3.29
Interest Inc( Exp) Net- Non- Op Total	-13.87	-21.64	-28.23	-34.84
Other Net	11.33	0.27	1.37	0.48
Net Income Before Taxes	2.26	1.16	1.10	0.28
Provisionfor Income Taxes	0.73	0.26	0.30	0.09
Net Income After Taxes	1.53	0.91	0.80	0.19
Net Income Before Extra Items	1.53	0.91	0.80	0.19
Net Income	1.53	0.91	0.80	0.19
Total Adjustmentsto Net Income	0.00	-	-	-
Income Availableto Com Excl Extra Ord	1.53	0.91	0.80	0.19
Income Availableto Com Incl Extra Ord	1.53	0.91	0.80	0.19
Diluted Net Income	1.53	0.91	0.80	0.19
Diluted Weighted Average Shares	0.75	0.75	0.75	0.76
Diluted EPS Excluding Extra Ord Items	2.03	1.20	1.06	0.25
Diluted Normalized EPS	2.03	1.29	1.14	0.25
Research Development	-	0.69	-	-
Unusual Expense( Income)	-	0.09	0.09	-